Target intelligence / Profile preview

Monoamine transporter protein (MAT (used collectively), but specific types are commonly known as DAT (dopamine transporter), NET (norepinephrine transporter), and SERT (serotonin transporter))

Target
MAT (used collectively), but specific types are commonly known as DAT (dopamine transporter), NET (norepinephrine transporter), and SERT (serotonin transporter)
Molecular classification
Transporter, Na^+/Cl^--dependent symporter, Member of the solute carrier 6 (SLC6) family, Neurotransmitter:sodium symporter (NSS) family
01

Overview

Monoamine transporter proteins are integral membrane proteins belonging to the solute carrier 6 (SLC6) family, primarily responsible for the active reuptake of the monoamine neurotransmitters dopamine, norepinephrine, and serotonin from the synaptic cleft into presynaptic neurons, thereby terminating neurotransmitter signaling and maintaining extracellular neurotransmitter homeostasis[1][3][5]. The major human members are the dopamine transporter (DAT, SLC6A3), norepinephrine transporter (NET, SLC6A2), and serotonin transporter (SERT, SLC6A4)[1][5]. These proteins utilize sodium and chloride ion gradients to drive the uptake process and are key pharmacological targets for numerous drugs affecting mood, attention, and reward, including antidepressants, stimulants, and drugs of abuse[3][4][7]. Dysfunction or dysregulation of these transporters is implicated in a range of mental health and neurodegenerative diseases[3][5][8].

Other names
Monoamine transportersMATsDopamine transporter (DAT)Serotonin transporter (SERT)Norepinephrine transporter (NET)Na^+/Cl^--dependent neurotransmitter transporters
02

Mechanism of action

Competitive inhibition of neurotransmitter reuptake (antidepressants, cocaine) Substrate-induced reverse transport/efflux (amphetamines) Allosteric modulation or stabilization of transporter conformational states

03

Biological functions

Neurotransmitter reuptakeRegulation of neurotransmitter homeostasis in the synaptic cleftSignal termination in synaptic transmissionMaintenance of monoaminergic neurotransmission
04

Disease associations

Neuropsychiatric disorders (e.g., depression, anxiety, ADHD, obsessive-compulsive disorder)Substance use disorderParkinson’s disease and other neurodegenerative disordersAutism spectrum disordersEpilepsy
05

Safety considerations

Neurotoxicity with prolonged blockade or substrate-induced efflux (as seen with chronic amphetamine or cocaine use)Risk of serotonin syndrome with excessive SERT inhibitionCardiovascular side effects (especially with NET inhibition)Drug-drug interactions leading to altered monoaminergic tone
06

Interacting drugs

Antidepressants (e.g., selective serotonin reuptake inhibitors [SSRIs], tricyclic antidepressants)

5 more in the full profile.

07

Biomarkers

Expression levels or genetic variants (e.g., SLC6A3 for DAT, SLC6A4 for SERT) can be used as biomarkers in pharmacogenetics and in some neuropsychiatric disease studies

Beyond the preview

Go deeper on Monoamine transporter protein (MAT (used collectively), but specific types are commonly known as DAT (dopamine transporter), NET (norepinephrine transporter), and SERT (serotonin transporter)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monoamine transporter protein (MAT (used collectively), but specific types are commonly known as DAT (dopamine transporter), NET (norepinephrine transporter), and SERT (serotonin transporter)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call